The Latest

Recent News of Bruce Willis’s Frontotemporal Dementia Diagnosis Raises Questions About Available Treatments

Frontotemporal Dementia (FTD) is a neurodegenerative disease that affects two brain structures:  the frontal lobes and the temporal lobes. The location of damage is distinct from that of Alzheimer’s Disease (AD), which is characterized by the degeneration of the brain structure known as the hippocampus. For each of these conditions, neurodegeneration can be readily quantified by the amount of shrinkage (loss of tissue) in these structures, which can be observed…READ MORE

Prevent Progression of Cognitive Decline and Make 2023 a Year to Remember

Today’s standard of care for complex diseases like Alzheimer’s Disease (AD) and related dementias fails to meet the needs of an aging patient population.  It falls short of providing adequate guidance for clinicians who bear the burden of this care gap. Complex diseases proceed from many contributing factors -- medical, genetic, and environmental -- that vary widely from person to person. Untangling the web of factors that contribute to neurodegeneration can…READ MORE

Florida Doctor Finds a Better Method to Treat Dementia

In February 2022, Dr. Federico Canavosio of Integrative Medical Care (IMC) in Vero Beach, FL started applying a new approach to memory care for patients aged 60 and older. IMC began working with medical AI company uMETHOD Health to deploy RestoreU, an evidence-based care program for patients at risk of developing Alzheimer’s Disease (AD), dementia, or other cognitive issues. “Cognitive impairment and related dementias are difficult to treat because they…READ MORE

Improving Health Outcomes for a Vulnerable Population on Veterans Day

Despite our annual expressions of gratitude to our veterans for all they’ve sacrificed, we fall short when it comes to their health and well-being. In addition to cancer, diabetes, and mental-health disorders, veterans suffer from Alzheimer’s Disease (AD) and other forms of dementia at high rates. Veterans currently under a physician’s care need a comprehensive workup and a care plan that addresses the factors that drive the progression of AD.…READ MORE

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer’s Disease Patients

NASHVILLE, Tenn., Nov. 9, 2022 /PRNewswire/ -- uMETHOD Health, a health technology company specializing in precision medicine for complex diseases, announces a partnership with PathGroup, one of largest independent laboratories in the United States. uMETHOD's AI-based care planning solution, RestoreU, pairs comprehensive testing from PathGroup with actionable treatment recommendations, aimed at lowering patient's risk of developing Alzheimer's and disease progression in its early stages. Read the full release.…READ MORE

What’s the connection between Alzheimer’s Disease (AD) and falls among senior adults?

uMETHOD Health is partnering with regional and national diagnostic laboratories and hundreds of physicians to identify and address the multiple factors that contribute to cognitive issues in seniors. The Raleigh, NC-based company produces leading-edge medical artificial intelligence (AI) and services to target complex diseases such as Alzheimer’s Disease (AD). On the 29th annual World Alzheimer’s Day, uMETHOD states there are multiple contributors involved in the progression of AD and they…READ MORE

uMETHOD, Getlabs partner to make personalized cognitive decline care plans accessible in Arizona

uMETHOD, which provides precision medicine software to treat cognitive decline, tapped at-home diagnostics provider Getlabs to supply mobile phlebotomies for its patients in Arizona. Blood tests are an essential part of the personalized care plans that uMETHOD provides, and the partnership seeks to make these tests accessible to patients with cognitive decline. Read the full article here.…READ MORE

uMETHOD’s AI software helps doctors assess and reduce risk of falls among patients with cognitive decline

uMETHOD Health is a technology company in Research Triangle Park, North Carolina, focused on treating the causes of com­plex diseases.  Its RestoreU METHOD uses patented artificial-intelligence (AI) software to identify the underlying factors that drive someone’s cognitive decline.  This software generates personalized care plans on how to prevent, slow, or even roll-back the progression of cognitive decline.  The software now identifies all the drugs someone may be taking that increase…READ MORE

Leading Alzheimer’s disease expert, Dr. Marwan Sabbagh describes how RestoreU optimizes brain health in Sonora Quest Webinar Series.

Dr. Marwan Sabbagh, an Alzheimer’s disease expert and geriatric neurologist at the Barrow Institute in Phoenix, AZ joined Rob Sherman, product manager at Sonora Quest to discuss how the health care community can help combat the rapid rise of Alzheimer's disease in Arizona using progressive and innovative solutions like RestoreU, offered by uMETHOD Health and Sonora Quest Laboratories. The conversation highlights Dr. Sabbagh's use of RestoreU to improve diagnostic confidence…READ MORE

RestoreU serves as the basis for Pinnacle Care Internal Medicine’s Memory Clinic

Pinnacle Care Internal Medicine’s co-founder, Dr. Ashish Sachdeva recently joined Bob Roth on Health Futures Radio in Phoenix, AZ to discuss COVID-19’s spillover effect on non-COVID patients. “Delayed care, forgone care, missed care. This is going to accumulate over time. The long-term effects from neglecting known and unknown disease diagnosis is going to be immense.” Says Dr. Sachdeva. In the interview, Dr. Sachdeva stresses his concern about the physical and…READ MORE